Permanent foramen ovale: when to close?

Similar documents
Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare


Speakers. 2015, American Heart Association 1

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

Cryptogenic Stroke: A logical approach to a common clinical problem

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke

Cryptogenic Strokes: Evaluation and Management

Patent Foramen Ovale: Diagnosis and Treatment

I, (Issam Moussa) DO NOT have a financial interest/arrangement t/ t or affiliation with one or more organizations that could be perceived as a real

How to Evaluate Patients with Cryptogenic Stroke

Management and Investigation of Ischemic Stroke By Etiology

PFO Management update

True cryptogenic stroke

How Can We Properly Manage Patients With Stroke of Undetermined Origin?

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Basilar Artery Atherosclerotic Plaques in Paramedian and Lacunar Pontine Infarctions A High-Resolution MRI Study

Small Vessel Stroke. Domenico Inzitari Careggi University Hospital Florence (Italy)

CEREBRO VASCULAR ACCIDENTS

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

Supplementary webappendix

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

GERIATRICS CASE PRESENTATION

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

TIA: Updates and Management 2008

PFO Closure for the Management of Migraine and Stroke

DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE. Matthew Starr, MD Stroke Attending

Cryptogenic Stroke: The role of silent Atrial Fibrillation

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do?

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.

TOP 3: EMBRACE. Lucy Vieira MD FRCP Neurologist MUHC. N Engl J Med Volume 370(26): June 26, David J.

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Nicolas Bianchi M.D. May 15th, 2012

Overlap of Diseases Underlying Ischemic Stroke The ASCOD Phenotyping

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Management of Atrial Fibrillation. Leon Ptaszek, MD, PhD, FACC, FHRS 25 March 2018

Alan Barber. Professor of Clinical Neurology University of Auckland

Antithrombotic Summit Basel 2012 Basel, 26. April Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel

TIA triage in Not all that glitters is gold

Cryptogenic Stroke: Finding Light in the Darkness

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect

CLOSE. Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018

PFO closure group total no. PFO closure group no. of males

Michael Horowitz, MD Pittsburgh, PA

10/19/12. Uncommon Causes of Stroke. José Biller, MD, FACP, FAAN, FAHA Disclosures. Dr. Biller has no disclosures to report

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute

2018 Update in Diagnosis and Management of Stroke

TIA as Acute Cerebrovascular Syndrome

DIFFERENT STROKES FOR DIFFERENT FOLKS!!

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need

Why Should We Treat PFO?

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

CT and MR Imaging in Young Stroke Patients

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC

Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health

FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema. Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M.

The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

RESPECT Safety Findings

Stroke School for Internists Part 1

Lesion patterns in patients with cryptogenic stroke with and without right-to-left-shunt

Why Treat Patent Forman Ovale

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Lacunar Infarct. Dr. Tapas Kumar Banerjee Medical Director & Chief Consultant Neurologist National Neurosciences Centre Calcutta

Branch Atheromatous Plaque: A Major Cause of Lacunar Infarction (High-Resolution MRI Study)

Vessel Wall Imaging of Intracranial Arterial Disease Commercial Interests

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow

Secondary Stroke Prevention: A Precautionary Tale

Defining Sub-Clinical Atrial Fibrillation and its management

Does ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack?

Causes and Mechanisms of Territorial and Nonterritorial Cerebellar Infarcts in 115 Consecutive Patients

Modena, 6 novembre Heart and Brain. Paolo Bovi

Watchman Implantation Case Presentation and Discussion

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Stroke/TIA. Tom Bedwell

Critical Review Form Therapy

PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL

Fabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier

Alan Barber. Professor of Clinical Neurology University of Auckland

Patients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

Embolic Stroke of Undetermined Source (ESUS) Lee Birnbaum, MD, MS Depts of Neurology and Neurosurgery UTHSCSA

Imaging Acute Stroke and Cerebral Ischemia

Clinical Prediction Rule for Treatment Change Based on Echocardiogram Findings in Transient Ischemic Attack and Non-Disabling Stroke

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

2015 Update in Diagnosis and Management of Stroke

PFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC

Transcription:

Permanent foramen ovale: when to close? Pierre Amarenco INSERM U-698 and Denis Diderot University - Paris VII Department of Neurology and Stroke Center Bichat hospital, Paris, France

PFO - Pathology TEE

PFO - Anatomy & Pathology FOP Thrombus TEE

PFO - Cryptogenic strokes - Patients <55 yrs OverellJR et al. Neurology 2000;55:1172-9

PFO + ASA OverellJR et al. Neurology 2000;55:1172-9

FOP-ASA: Recurrent stroke Mas et al N Engl J Med 2001;345:1740-6 1 yr (IC 95%) 2 yrs (IC 95%) 3 yrs (IC 95%) 4 yrs (IC 95%) Mean annual risk No PFO no ASA 2.0 (0.4-3.6) 3.7 (1.6-5.8) 4.2 (1.8-6.6) 4.2 (1.8-6.6) 1.1 PFO only 1.8 (0.05-3.6) 1.8 (0.05-3.6) 2.3 (0.3-4.3) 2.3 (0.3-4.3) 0.6 ASA only 0 0 0 0 0 PFO + ASA 2.0 (0-5.8) 4.0 (0-9.4) 6.3 (0-13.2) 15.2 (1.8-28.5) 4.0 <55 y-o, all on Aspirin 300 mg/d

PFO an Recurrent Stroke Meta-analysis Almekhlafi MA et al. Neurology 2009;73:89-97

Case -1 65 y-o man no risk factor sudden acute left pure motor hemiparesis DWI paramedian pontine infarct normal work-up: TCD, Duplex, MRA, ECG TEE : PFO

High-Resolution MRI of the basilar artery Paramedian Pontine Infarcts (branch disease) Klein, Lavallée, Amarenco. Neurology 2005;64:551-552

Case - 2 70 y-o man sudden pure motor right-sided hemiparesis with dysarthria Total recovery within 8 days 1 year before: dysarthria and clumsy hand, totally regressive MRI: old small infarct in the corona radiata and new capsular infarct ECG: sinus rhythm TCD and Carotid duplex normal MRA extra/intracranial: normal TEE: PFO and ASA

Small Deep Atherothrombotic Brain Infarct

Lacune Arterioles <150-300 µm Lipid deposits Lipohyalinosis Hyalinosclerosis

Case - 3 PFO in the young A 25 y-o woman had a long flight from Sydney to Paris. The day after she woke up with a fronto-orbital headache. Self treatment with a triptan with weak success In the evening: massive, dense left-sided hemiplegia with total resolution within 2 hours Work-up negative: TCD, Carotid duplex, MRI, MRA, ECG, no hypercoagulation TEE : PFO and ASA

Case - 3 Fat-saturated MRI

Case - 4 41 y-o man woke up at 4:00 am with severe occipital headache Unsteadiness of walk Day after: ER: left sided dysmetria and cerebellar ataxia BP 136/88 Ultrasound ex: carotid normal, low flow in V3, normal basilar artery, hypoplastic right VA MRI: acute SCA infarct MRA and XRA normal except right VA hypoplastic TEE : FOP + ASA

Case - 4 Follow-up HR-MRI on day 18

Wrong PFO Closure

What is a «cryptogenic stroke» or «stroke of indetermined cause»?

CAUSES of STROKE Stroke 80% 20% Ischemic Hemorrhagic Large Artery Atherosclerosis Cardiac Sources Small Artery Disease Dissection and other causes Unknown cause 20% 15% 25% 2 à 3% 30-40%

Usual classification systems Consider only the most likely cause Neglect other possible, or potential cause Neglect non causally related underlying disease - e.g., MRI evidences of small vessel changes such as severe leukoaraiosis - e.g., documented atherosclerotic disease in arteries not supplying teh ischemic field) When two causes co exist, they are classified into one mixed group of «unknown cause», including: Cases with co existing actual causes Cases with insufficient work-up Cases with thorough work-up but with no cause detected

Usual classification systems Based on these classification systems, publications looking at new potential cause or biomarker, or genetic association studies analyze 5 «rigid» groups : LAA, SVD, CE, Other and Unknown causes

A-S-C-0 http://www.asco-classification.org Findings in each patient are described by an ASCO «code» A: atherothrombosis S: small vessel disease C: cardiac embolism O: other cause Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. A new approach to stroke subtyping : the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009 ;27 :502-508

A-S-C-0 http://www.asco-classification.org Each of the 4 A-S-C-O is graded: 1: Definitely a potential cause of the index stroke 2: Causality uncertain 3: Unlikely a direct cause of the index stroke (but disease is present) 0: no evidence of disease 9: insufficient work-up to grade

AMISTAD cohort (preliminary on the first 103 patients among 650) Distribution using TOAST 18% co-existing causes

ASCO vs. TOAST Among 52 pts classified «Undetermined cause» by TOAST Athero Small vessel Cardiac 52 52 52 52

TOAST vs ASCO Analysis: out of 103 cases TOAST: proportion of SVD n=10 [but UND n=7 (LAA+CE+SVD n=3, CE+SVD n=4)] ASCO: proportion of SVD n=48 [S1 (n=14), S2 (N=6), S3 (28)] S0 n=49 S9 n=6 Analysis: out of 103 cases TOAST: proportion of LAA n=15 [but UND n=15 (LAA+CE n=12, LAA+CE+SVD n=3)] ASCO: proportion of LAA n=86 [A1 (n=25), A2 (N=22), A3 (39)] A0 n=16 A9 n=1

ECG monitoring in SUC Elijovich L, Josephson SA, Fung GL, Wmith WS. J Stroke Cerebrovasc Dis. 2009;18(3):185-9 218 Ischemic Stroke 36 SUC 20 SUC evaluated with 30 days cardiac event monitor 4 (20%) Atrial fibrillation When it is not atrial fibrillation, it can be. atrial fibrillation

Detection of AF Telemetry: 4 to 8% 24hr Holter ECG 1% to 5% Pts with >7 premature atrial beats/24 hr on initial holter had a 26% occurrence of AF if monitoring is extended to 7 days 30 days event recorder (new generation): automatic detection of brady or tachy-arrhythmias 149 pts: 5.7% (mean monitoring duration 159 hrs) 60 pts: 6.7% (70.1±30.9 hrs) 56 pts: 23% (21 days) Implantable loop recorder (14 months monitoring) No available evidences

Conclusions PFO associated with thrombus is likely a source of cerebral embolism PFO is more frequent in patients with TIA/Stroke of unknown cause PFO may increase the risk of recurrent stroke, but this will only be proven by randomised trials conducted in patients with stroke of unknown cause However, the diagnosis of stroke of unknown cause is very difficult Undetected atrial fibrillation is likely underestimated The role of atherosclerotic disease is underestimated Small vessel disease is highly prevalent Carotid or vertebral artery dissection in the young must be thoroughly search for in patients younger than 60 years

Take home message cryptogenic stroke is the most difficult diagnosis to make Consider PFO + ASA as a potential cause only if you are confident with your negative workup Efficacy of PFO closure in this context remains to be proven

Conclusions Pending a RCT comparing aspirin, anticoagulant and PFO closure PFO alone : annual risk 0.6% -->aspirin PFO alone and Recurrent (true) cryptogenic --> PFO closure vs. OA PFO + DVT or PE: PFO closure vs. OA